Keywords: تیراپازامین; Polymeric nanomedicines; Peptide; Cancer therapy; Therapeutic delivery; AF; aminoflavone; ANG; angiopep-2; BBB; blood brain barrier; BCECs; brain capillary endothelial cells; BP; bortezomib-pinanediol; bPEISS; bioreducible branched polyethylenimine; BPLP;
مقالات ISI تیراپازامین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تیراپازامین; 3D; three dimensional; DIV; days in vitro; DMEM; Dulbecco's modified Eagle's medium; ECM; extracellular matrix; FBS; fetal bovine serum; HBSS; Hanks' balanced salt solution; HIF-1α; hypoxia inducible factor-1α; HS; horse serum; PBS; phosphate buff
Cell cultures in drug discovery and development: The need of reliable in vitro-in vivo extrapolation for pharmacodynamics and pharmacokinetics assessment
Keywords: تیراپازامین; 3Rs; Reduction, Replacement, Refinement; PBPK; physiologically based pharmacokinetic; 2D; two-dimensional; 3D; three-dimensional; HTS; high-throughput screening; IVIVE; in vitro-in vivo extrapolation; ADME; absorption, distribution, metabolism and excreti
Monitoring and Targeting Anti-VEGF Induced Hypoxia within the Viable Tumor by 19F-MRI and Multispectral Analysis
Keywords: تیراپازامین; VEGF-A; Vascular endothelial growth factor A; TPZ; Tirapazamine; MS; Multispectral analysis; MRI; Magnetic resonance imaging; R1; Spin-lattice, or longitudinal, relaxation rate; EC50; Half maximal effective concentration; PFC; Perfluorocarbon; KM; K-mea
When DNA repair goes wrong: BER-generated DNA-protein crosslinks to oxidative lesions
Keywords: تیراپازامین; Cu(OP)2; 1,10 copper-o-phenanthroline; dL; 2-deoxyribonolactone; 5â²-dRp; 5â²-deoxyribose-5-phosphate; AP; apurinic/apyrimidinic (abasic); Polβ DNA polymerase β DPC; DNA-protein crosslink; MEF; mouse embryonic fibroblast; Oxa; oxanine; TPZ; ti
The flavoprotein FOXRED2 reductively activates nitro-chloromethylbenzindolines and other hypoxia-targeting prodrugs
Keywords: تیراپازامین; FOXRED2; NitroCBI; TH-302; PR-104; Hypoxia-targeting prodrug; Tirapazamine
Enhanced antitumor efficacy of cisplatin by tirapazamine–transferrin conjugate
Keywords: تیراپازامین; Transferrin; Tirapazamine; Cisplatin; Targeting anti-tumor effect; Tissue distribution
The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression
Keywords: تیراپازامین; TPZ; Tirapazamine; HIF-1; hypoxia inducible factor-1; VEGF; vascular endothelial growth factor; GLUT1; glucose transporter 1; ELISA; enzyme-linked immunosorbent; EPO; erythropoietin; GPI; glucose phosphate isomerase; GDEPT; gene-directed enzyme prodrug th
Homologous recombination repair-dependent cytotoxicity of the benzotriazine di-N-oxide CEN-209: Comparison with other hypoxia-activated prodrugs
Keywords: تیراپازامین; Hypoxia-activated prodrug; Homologous recombination repair; Redox cycling; CEN-209; Tirapazamine; TH-302
Ultrasensitive electrochemical sensing of the anticancer drug tirapazamine using an ordered mesoporous carbon modified pyrolytic graphite electrode
Keywords: تیراپازامین; Ordered mesoporous carbon; Tirapazamine; Electrochemical sensor; Ultrasensitive determination
Exploring vascular dysfunction caused by tirapazamine
Keywords: تیراپازامین; Carbogen; NOS; Tirapazamine; Vasculature; Tubulin; SiHa; HCT-116; SCCVII;
Effects of fluctuating oxygenation on tirapazamine efficacy: Theoretical predictions
Keywords: تیراپازامین; Fluctuating hypoxia; Hypoxic cytotoxins; Tirapazamine;
Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer
Keywords: تیراپازامین; Reirradiation; Recurrent head-and-neck cancer; Tirapazamine; Hypoxic cell sensitizer;
A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study
Keywords: تیراپازامین; Tirapazamine; Recurrent platinum-sensitive ovarian cancer; Primary peritoneal cancer
Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts
Keywords: تیراپازامین; Hypoxia; Tirapazamine; Vasculature; Tumour
Radiation sensitization with redox modulators: A promising approach
Keywords: تیراپازامین; Radiation sensitizer; Radiation therapy; Redox modulator; Tirapazamine; AQ4N; RSR13; MGd; HIF-1 inhibitor;